Skip to Content
Merck
  • [Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)].

[Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] (2010-12-15)
S Ia Loginova, S V Borisevich, O M Shkliaeva, V A Maksimov, V P Bondarev, V E Nebol'sin
ABSTRACT

The experimental study of the Ingavirin efficacy against the influenza virus A (H5N1) on intranasally-infected albino mice vs. Tamiflue and Arbidol showed that when used for the prophylaxis, urgent prophylaxis and therapy it was effective in the protectiom of the animals from death. The efficient dose for the prophylaxis of the influenza infection was 5 mg/kg (protective efficacy of 46.7%) and for the urgent prophylaxis and therapy it was 15 mg/kg (protective efficacy of 40.0 and 35.0% respectively).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Arbidol hydrochloride, ≥98% (HPLC)